8-KEarnings & ResultsExhibits & Filings

Guardant Health, Inc. 8-K Report, Financial Results (Nov 6, 2024)

Filed November 6, 2024For Securities:GH

Summary

Guardant Health, Inc. (GH) has filed an 8-K report on November 6, 2024, primarily to furnish a press release detailing its financial results for the fiscal quarter ended September 30, 2024. While the 8-K itself does not contain the detailed financial figures, it serves as the official notification mechanism for the company's quarterly performance announcement. Investors should refer to the furnished press release (Exhibit 99.1) for specific revenue, earnings, and operational metrics for the third quarter of 2024. This filing is a routine step for publicly traded companies to disseminate important financial information to the market in a timely manner. The key takeaway for investors is that the company has reported its Q3 2024 financial results. The 8-K's purpose is to make this information publicly available through the attached press release. Investors seeking a comprehensive understanding of Guardant Health's financial health, performance trends, and any forward-looking guidance should meticulously review the content of Exhibit 99.1. The filing itself, beyond referencing the press release, provides standard legal disclaimers regarding the 'furnished' nature of the information.

Key Highlights

  • 1Guardant Health filed an 8-K on November 6, 2024, to announce its Q3 2024 financial results.
  • 2The detailed financial results are provided in a press release, furnished as Exhibit 99.1 to the 8-K.
  • 3Investors must consult Exhibit 99.1 for specific revenue, earnings, and operational data for the quarter ended September 30, 2024.
  • 4The filing includes standard legal disclaimers stating the information is furnished and not 'filed' for certain SEC purposes.
  • 5This is a routine disclosure for publicly traded companies to update stakeholders on quarterly performance.

Frequently Asked Questions

The primary purpose of this 8-K filing is to officially announce and make publicly available Guardant Health's financial results for the fiscal quarter ended September 30, 2024, through an accompanying press release.

The detailed financial results are located in the press release furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this exhibit for specific financial and operational metrics.

No, according to the filing's language, the information furnished in this 8-K (including Exhibit 99.1) is generally considered 'furnished' and not 'filed' for purposes of Section 18 of the Exchange Act or otherwise subject to its liabilities, unless expressly incorporated by reference into another filing.

The 8-K filing itself does not contain forward-looking guidance. Any such information would be detailed within the press release (Exhibit 99.1), which is the source for the company's Q3 2024 results and potentially its outlook.